SARS-CoV2 infection: functional and morphological cardiopulmonary changes in elite handball players.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
07 09 2021
Historique:
received: 06 05 2021
accepted: 12 08 2021
entrez: 8 9 2021
pubmed: 9 9 2021
medline: 15 9 2021
Statut: epublish

Résumé

There is increasing evidence of cardiac involvement post-SARS-CoV-2 infections in symptomatic as well as in oligo- and asymptomatic athletes. This study aimed to characterize the possible early effects of SARS-CoV-2 infections on myocardial morphology and cardiopulmonary function in athletes. Eight male elite handball players (27 ± 3.5 y) with past SARS-CoV-2 infection were compared with four uninfected teammates (22 ± 2.6 y). Infected athletes were examined 19 ± 7 days after the first positive PCR test. Echocardiographic assessment of the global longitudinal strain under resting conditions was not significantly changed (- 17.7% vs. - 18.1%). However, magnetic resonance imaging showed minor signs of acute inflammation/oedema in all infected athletes (T2-mapping: + 4.1 ms, p = 0.034) without reaching the Lake-Louis criteria. Spiroergometric analysis showed a significant reduction in VO2max (- 292 ml/min, - 7.0%), oxygen pulse (- 2.4 ml/beat, - 10.4%), and respiratory minute volume (VE) (- 18.9 l/min, - 13.8%) in athletes with a history of SARS-CoV2 infection (p < 0.05, respectively). The parameters were unchanged in the uninfected teammates. SARS-CoV2 infection caused impairment of cardiopulmonary performance during physical effort in elite athletes. It seems reasonable to screen athletes after SARS-CoV2 infection with spiroergometry to identify performance limitations and to guide the return to competition.

Identifiants

pubmed: 34493765
doi: 10.1038/s41598-021-97120-x
pii: 10.1038/s41598-021-97120-x
pmc: PMC8423785
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

17798

Informations de copyright

© 2021. The Author(s).

Références

Immunol Cell Biol. 2000 Oct;78(5):510-22
pubmed: 11050534
Acta Physiol Scand. 1992 Jan;144(1):23-9
pubmed: 1595350
Eur Heart J. 2020 Nov 14;41(43):4191-4199
pubmed: 32845299
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Neth Heart J. 2020 Jul;28(7-8):391-395
pubmed: 32662058
Int J Cardiovasc Imaging. 2020 Aug;36(8):1407-1416
pubmed: 32367188
J Sports Med Phys Fitness. 2016 Dec;56(12):1583-1591
pubmed: 26986993
Br J Sports Med. 2020 Nov 12;:
pubmed: 33184114
Medicina (Kaunas). 2021 Mar 17;57(3):
pubmed: 33802881
Eur Radiol. 2021 Feb;31(2):1090-1099
pubmed: 32860146
Front Physiol. 2020 Oct 15;11:588784
pubmed: 33178050
J Cardiovasc Echogr. 2020 Oct-Dec;30(4):206-210
pubmed: 33828942
Clin Res Cardiol. 2020 Dec;109(12):1549-1566
pubmed: 32803387
JACC Cardiovasc Imaging. 2020 Dec;13(12):2635-2652
pubmed: 33303102
PLoS Negl Trop Dis. 2011 Jul;5(7):e1239
pubmed: 21811643
Int J Cardiovasc Imaging. 2020 Oct;36(10):1855-1885
pubmed: 32462448
Clin Sports Med. 2011 Jul;30(3):525-36
pubmed: 21658546
Int J Cardiovasc Imaging. 2021 Aug;37(8):2369-2386
pubmed: 33738612
JAMA Cardiol. 2021 Jan 1;6(1):116-118
pubmed: 32915194
Cureus. 2020 May 8;12(5):e8021
pubmed: 32528760
J Sports Med Phys Fitness. 2021 Jul;61(7):977-982
pubmed: 33269880
Herz. 2020 May;45(3):230-232
pubmed: 32140732
Int J Cardiovasc Imaging. 2016 Jun;32(6):975-81
pubmed: 26920720
Br J Sports Med. 2020 Oct;54(19):1157-1161
pubmed: 32878870
PLoS One. 2020 Jul 23;15(7):e0235791
pubmed: 32702711
J Cardiovasc Pharmacol Ther. 2021 Jan;26(1):12-24
pubmed: 32924567
JAMA Cardiol. 2021 May 27;:
pubmed: 34042947
Int J Cardiol. 2017 Jun 15;237:67-70
pubmed: 28318658
Can J Cardiol. 2021 Aug;37(8):1165-1174
pubmed: 33248208

Auteurs

S Fikenzer (S)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany. sven.fikenzer@medizin.uni-leipzig.de.

A Kogel (A)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

C Pietsch (C)

Institut für Medizinische Mikrobiologie und Virologie - Fachbereich Virologie, Universitätsklinikum Leipzig, Johannisallee 30, 04103, Leipzig, Germany.

D Lavall (D)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

St Stöbe (S)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

U Rudolph (U)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

U Laufs (U)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

P Hepp (P)

Klinik und Poliklinik für Orthopädie, Unfallchirurgie und Plastische Chirurgie, Universitätsklinikum, Leipzig, Germany.

A Hagendorff (A)

Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstr. 20, 04103, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH